Cubist Pharmaceuticals Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (28)

Latest Posts

About This Stock More About This Stock
Biotech Winners 2015: Rayno Mid Caps Were Up 29.6%
Article By: Rod Raynovich
Sunday, January 3, 2016 10:00 PM EDT
We previously reviewed the Rayno Small Cap Portfolio which was up 38.1% in Q4 2015 and the Mid-Caps also beat despite a big loss by Clovis Oncology after the FDA required more data on its lung cancer drug.
In this article: MRK, CRIS, GERN, IBB, REGN, SGEN, ALKS, CBST, CLVS, VRTX, PCYC, XLV, ABBV
Read
2015 Rayno Biopharmaceutical Stock Portfolio
Article By: Rod Raynovich
Tuesday, July 14, 2015 9:00 PM EDT
The Biotech Bull Market Is Now in its Sixth Year Led By Biopharmaceuticals. Here is the current Rayno Biopharmaceutical Stock Portfolio as of 7/13 prices
In this article: ALXN, BIIB, CBST, CLDX, FCSC, GILD, OPTR, PCYC, REGN, SGEN, VPHM Also: FBT, IBB, XBI
Read
YTD Review Part 1-FBT Up 49%
Article By: Rod Raynovich
Friday, December 12, 2014 3:33 AM EDT
Biotech stocks are following the long term seasonal bullish trend surging in Q4 and up about 49 % YTD. The easiest way to invest in the biotech market is with the ETF First Trust NYSE Arca Biotechnology Index (FBT).
In this article: ALXN, RGEN, SGEN, ALKS, BIIB, CBST, GILD, PCYC, FBT
Read
Energy Weakness Rolls Over To Biotech Stocks
Article By: Rod Raynovich
Wednesday, December 10, 2014 5:27 PM EDT
Healthcare and life science stocks have been a safe haven from recent market headwinds but today risk is off across the board.
In this article: MRK, CBST, ZIOP, FBT, GBIM, KITE, BLUE
Read
E Cubist Shares Rise 35% After Merck Agrees To Acquire Company For $9.5 Billion
Article By: Terry Chrisomalis
Monday, December 8, 2014 6:38 PM EDT
Later in the day, both stocks took a hit as a judge agrees that Hospira can market a generic version of Cubist's lead drug as early as 2016.
In this article: HSP, MRK, CBST
Read

PARTNER HEADLINES

Latest Tweets for $CBST

No tweets yet!